Have a personal or library account? Click to login

The role of Pazopanib in Soft Tissue Sarcoma: A comprehensive review of the literature

Forum of Clinical Oncology
Volume 6 (2015): Issue 3 (September 2015)
By:
Open Access
|Dec 2015

Authors

George Fotopoulos

fotopoulos.george1@gmail.com

George Pentheroudakis

DOI: https://doi.org/10.1515/fco-2015-0012 | Journal eISSN: 1792-362X | Journal ISSN: 1792-345X
Journal RSS Feed
Language: English
Page range: 13 - 21
Published on: Dec 17, 2015
Published by: Helenic Society of Medical Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 2 times per year
Keywords:
Soft tissue sarcoma,
Pazopanib,
STS,
VEGFR2,
TKIs,
Angiogenesis,
Advanced sarcoma treatment,
Targetted therapy for sarcoma
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology

© 2015 George Fotopoulos, George Pentheroudakis, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 6 (2015): Issue 3 (September 2015)Next article